Will Humana report positive year-over-year Stars quality metric improvement in Q2 2026 operational update?

Management already claims CTMs and HRAs are running ahead year-over-year. The question asks whether management will REPORT positive improvement, not whether external data confirms it. Given management's incentive to demonstrate Stars progress (it's the linchpin of the 2028 earnings power narrative), and given that CTMs and HRAs are within their control to some degree, they will almost certainly provide metrics that show improvement. The harder question is whether the improvement is sufficient for actual Stars rating improvement, but this market only requires management to report positive YoY improvement. High probability of YES.

This is partly a management communication question. Humana has made the 2028 Stars recovery the centerpiece of their investment narrative. The Q2 operational update will be designed to maintain investor confidence. Management has already laid the groundwork by citing early positive signals. The risk of reporting flat or declining metrics is low because: (1) the 2025 baseline was the trough year (easy comp), (2) management has focused resources on Stars improvement, and (3) selective metric reporting can always find favorable datapoints. The main risk is if CAHPS surveys (patient satisfaction, reported mid-year) show deterioration driven by benefit reductions or new member confusion.

The resolution criteria includes 'fails to provide an update by August 2026' as resolving NO, which adds a scenario where management avoids disclosure. However, given the centrality of Stars to the thesis, management is unlikely to go silent. The more substantive question: with the massive influx of new members (25% growth), CAHPS scores could deteriorate because new members often have lower satisfaction during onboarding. HEDIS completion rates might improve because management is investing in outreach. The composite picture is likely to be mixed — some metrics up, some down. Management will frame the positives. The probability of reporting at least some measurable improvement across some metrics is high.

Management has committed heavily to the 2028 Stars recovery narrative. They've already provided early positive indicators (CTMs, HRAs). The Q2 update will likely show measurable improvement on at least some metrics given: (1) 2025 was the trough baseline making YoY comparisons favorable, (2) management is investing significantly in Stars improvement programs, and (3) the resolution criteria accepts ANY measurable improvement in ANY Stars metric. The question is effectively whether management will report bad news on Stars during their Q2 disclosure. This is unlikely given their narrative strategy.

A more skeptical view: Stars is measured on a CURVE relative to industry. Even if Humana's absolute metrics improve, if the entire industry improves similarly, Humana's relative position may not change. Furthermore, the 25% new member growth creates real operational challenges — call center wait times, provider network strain, and benefit confusion that directly impact CAHPS and CTM measures. Management may report process metrics (HRA completion, outreach calls) as improvements while acknowledging that outcome metrics (CAHPS, complaint rates) are mixed. The resolution criteria is broad enough that some improvement somewhere is likely, but genuine quality improvement is less certain.

The base rate for management reporting positive progress on their stated top priority is high. The resolution criteria is permissive — it requires 'measurable year-over-year improvement' in any Stars operational metric. Given the investment in Stars programs, at least some metrics should show improvement. The main risk is if Q2 data reveals that new member growth has materially degraded quality metrics, forcing management to acknowledge setbacks. This is possible but unlikely to be the dominant narrative in management communications. Probability meaningfully above coin-flip.

Management is heavily invested in Stars recovery narrative. CTMs and HRAs already reported as ahead YoY. Trough baseline makes improvement easy. Management will report positive metrics. High probability of YES.

Stars improvement is management's #1 priority with significant resources allocated. The question is whether reported improvement is meaningful or just cherry-picked metrics. Either way, some reported improvement is highly likely. Risk is new member dilution of quality scores, but management can contextualize this. Probability well above coin-flip.

Several factors favor YES: trough baseline, management commitment, existing positive signals (CTMs, HRAs). Key risk: 25% membership growth may overwhelm quality improvement efforts. But resolution criteria only requires reporting of improvement, not actual Stars rating change. Management communication bias favors reporting positive data. Moderate-high probability.